Advances of cancer therapy by nanotechnology.
Recent developments in nanotechnology offer researchers opportunities to significantly transform cancer therapeutics. This technology has enabled the manipulation of the biological and physicochemical properties of nanomaterials to facilitate more efficient drug targeting and delivery. Clinical investigations suggest that therapeutic nanoparticles can enhance efficacy and reduced side effects compared with conventional cancer therapeutic drugs. Encouraged by rapid and promising progress in cancer nanotechnology, researchers continue to develop novel and efficacious nanoparticles for drug delivery. The use of therapeutic nanoparticles as unique drug delivery systems will be a significant addition to current cancer therapeutics.
Wang
Xu
X
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Wang
Yiqing
Y
Chen
Zhuo Georgia
ZG
Shin
Dong M
DM
Nat Rev Drug Discov. 2008 Sep;7(9):771-82
18758474
Clin Chim Acta. 1998 Jul 28;275(2):175-84
9721075
J Control Release. 2003 Dec 5;93(2):151-60
14636721
Leuk Lymphoma. 2005 Jun;46(6):795-802
16019523
Anticancer Drugs. 2001 Apr;12(4):315-23
11335787
Int J Nanomedicine. 2007;2(4):567-83
18203425
J Clin Oncol. 2003 Jan 1;21(1):148-57
12506184
J Am Chem Soc. 2002 Nov 27;124(47):13982-3
12440882
J Infus Nurs. 2007 Mar-Apr;30(2):89-95; quiz 120
17413493
Clin Cancer Res. 2004 Jun 1;10(11):3708-16
15173077
Int J Pharm. 2004 Aug 20;281(1-2):129-32
15288350
J Clin Oncol. 2002 Mar 15;20(6):1668-76
11896118
Anticancer Res. 2002 Jul-Aug;22(4):2131-5
12174894
Br J Cancer. 2005 Sep 19;93(6):678-87
16222314
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):703-11
15701859
Curr Cancer Drug Targets. 2004 Jun;4(4):313-26
15180497
Adv Drug Deliv Rev. 2004 Apr 23;56(7):1023-50
15066758
Expert Opin Pharmacother. 2006 Jun;7(8):1041-53
16722814
Br J Cancer. 2007 Jul 16;97(2):170-6
17595665
Head Neck. 2009 Apr;31(4):475-81
19072997
Curr Drug Deliv. 2005 Oct;2(4):369-81
16305440
Cancer Chemother Pharmacol. 2008 Apr;61(4):579-85
17520255
J Clin Oncol. 1997 Feb;15(2):653-9
9053490
Cancer Chemother Pharmacol. 2005 Apr;55(4):323-332
15517271
Ann Oncol. 2001 Apr;12(4):493-6
11398881
Acc Chem Res. 2001 Mar;34(3):181-90
11263876
Int J Hyperthermia. 1994 Jul-Aug;10(4):457-83
7963805
J Clin Pathol. 1983 May;36(5):539-45
6302135
Crit Rev Ther Drug Carrier Syst. 1999;16(3):245-88
10706520
Bioconjug Chem. 2001 Jan-Feb;12(1):129-33
11170375
Bioconjug Chem. 2000 Mar-Apr;11(2):131-9
10725088
Cancer Metastasis Rev. 2006 Mar;25(1):9-34
16680569
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20
16606824
Clin Cancer Res. 2001 Feb;7(2):223-5
11234871
Cancer Res. 2003 Jul 15;63(14):4062-6
12874007
Angew Chem Int Ed Engl. 1999 Apr 1;38(7):884-905
29711851
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5715-21
17379663
Eur J Cancer. 1996 Jun;32A(6):1070-81
8763349
Anal Biochem. 2005 Jan 15;336(2):213-20
15620886
J Control Release. 2004 Nov 24;100(2):247-56
15544872
Nihon Rinsho. 2006 Feb;64(2):316-21
16454187
Protein Expr Purif. 2002 Dec;26(3):455-61
12460770
Cancer Res. 2000 Aug 1;60(15):4251-5
10945638
J Clin Oncol. 2005 Nov 1;23(31):7794-803
16172456
Drug Resist Updat. 2003 Oct;6(5):271-9
14643297
Cytokine. 2000 Nov;12(11):1691-701
11052821
Clin Cancer Res. 2005 Jun 1;11(11):4136-43
15930349
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5182-7
10220440
Adv Drug Deliv Rev. 2003 Feb 10;55(2):217-50
12564978
Gynecol Oncol. 2004 Apr;93(1):229-32
15047241
Chem Rev. 1999 Jul 14;99(7):1665-1688
11849007
Cancer Res. 2006 Oct 15;66(20):10048-56
17047068
Pharm Res. 2006 Jan;23(1):1-30
16392022
Curr Opin Mol Ther. 2003 Jun;5(3):326-30
12870445
Adv Drug Deliv Rev. 2004 Sep 22;56(11):1649-59
15350294
J Mol Biol. 1964 May;8:660-8
14187392
Cancer. 2006 Aug 1;107(3):459-66
16795065
Bioconjug Chem. 2002 May-Jun;13(3):462-7
12009934
Cancer Invest. 2005;23(8):671-6
16377585
Invest New Drugs. 2002 Aug;20(3):343-9
12201498
Biochim Biophys Acta. 2004 May 27;1663(1-2):167-77
15157619
Prog Clin Biol Res. 1990;343:85-93
2198586
Br J Cancer. 2004 Jun 14;90(12):2261-7
15150611
Pharmacol Ther. 2007 Feb;113(2):429-41
17208306
Oncogene. 2004 Apr 29;23(20):3613-21
15034547
Angew Chem Int Ed Engl. 2004 Nov 26;43(46):6323-7
15558662
Science. 2004 Mar 19;303(5665):1818-22
15031496
Cancer Res. 2005 Jun 15;65(12):5317-24
15958579
J Control Release. 2005 Mar 21;103(2):405-18
15763623
Int J Pharm. 2005 May 30;296(1-2):151-61
15885467
Cardiovasc Toxicol. 2007;7(2):72-4
17652807
Adv Drug Deliv Rev. 2000 Mar 30;41(2):147-62
10699311
Toxicol Lett. 2006 Feb 20;161(2):115-23
16165331
Toxicol Appl Pharmacol. 1995 Feb;130(2):272-9
7871540
Acta Biochim Pol. 2001;48(1):199-208
11440170
Nat Biotechnol. 2006 Oct;24(10):1211-7
17033654
J Am Chem Soc. 2008 Aug 13;130(32):10643-7
18642918
Pharm Res. 1998 Oct;15(10):1552-6
9794497
Langmuir. 2004 Dec 21;20(26):11726-31
15595804
Expert Opin Investig Drugs. 2004 Nov;13(11):1501-8
15500397
Mol Pharm. 2005 Sep-Oct;2(5):373-83
16196490
J Immunol. 2002 Jul 1;169(1):476-86
12077279
Clin Cancer Res. 2004 May 15;10(10):3386-95
15161693
Nat Biotechnol. 2008 Jan;26(1):83-90
18157119
Cancer Res. 2006 Jul 1;66(13):6732-40
16818648
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2586-91
18272481
Br J Cancer. 2004 Jul 5;91(1):50-5
15187995
Cancer Chemother Pharmacol. 2006 May;57(5):654-62
16133526
Breast Cancer Res Treat. 2008 Mar;108(2):241-50
17476588
Br J Cancer. 2004 Nov 15;91(10):1775-81
15477860
Invest New Drugs. 1993 May-Aug;11(2-3):187-95
7505268
Cancer Chemother Pharmacol. 2006 Dec;58(6):759-64
16847673
Clin Cancer Res. 2008 Mar 15;14(6):1888-96
18347192
Drug Discov Today. 2001 Apr 1;6(8):427-436
11301287
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1252-65
18558452
Nat Biotechnol. 2008 Jul;26(7):799-807
18587385
Cancer Chemother Pharmacol. 2007 Sep;60(4):523-33
17308894
J Control Release. 2006 Sep 12;114(3):300-6
16884806
Angew Chem Int Ed Engl. 2008;47(28):5122-35
18574805
Invest New Drugs. 2007 Aug;25(4):385-90
17364234
Acc Chem Res. 2001 Mar;34(3):249-56
11263883
Oncogene. 2006 Aug 7;25(34):4633-46
16892078
Mol Pharm. 2005 May-Jun;2(3):194-205
15934780
Crit Rev Ther Drug Carrier Syst. 1985;1(4):311-74
2420476
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17356-61
18978032
Chem Commun (Camb). 2008 Dec 28;(48):6570-2
19057782
Cancer Chemother Pharmacol. 2003 Nov;52(5):424-30
12904897
Nat Rev Drug Discov. 2003 May;2(5):347-60
12750738
Pharm Res. 2007 Jun;24(6):1029-46
17385025
J Control Release. 2001 Dec 13;77(3):191-8
11733087
J Chromatogr B Biomed Sci Appl. 1997 Nov 21;702(1-2):181-91
9449570
Clin Adv Hematol Oncol. 2005 May;3(5):348-9
16167008
Adv Drug Deliv Rev. 2002 Sep 13;54(5):695-713
12204599
Clin Cancer Res. 2006 Mar 1;12(5):1606-14
16533788
Cancer Metastasis Rev. 1987;6(4):559-93
3327633
J Control Release. 1999 Jun 28;60(1):121-8
10370176
Toxicol Appl Pharmacol. 2008 Nov 1;232(3):418-27
18708083
CA Cancer J Clin. 2008 Mar-Apr;58(2):97-110
18227410
Br J Cancer. 2004 Jun 1;90(11):2085-91
15150584
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54
17875985
Br J Cancer. 1999 Sep;81(1):99-107
10487619
Br J Cancer. 2006 Oct 9;95(7):822-8
16969346
Clin Cancer Res. 2008 Mar 1;14(5):1310-6
18316549
J Biomed Mater Res. 1996 Jan;30(1):53-65
8788106
Br J Cancer. 2005 Apr 11;92(7):1240-6
15785749
Ann Oncol. 2007 Dec;18(12):2009-14
17785767
Mol Ther. 2007 Jun;15(6):1145-52
17440441
Clin Cancer Res. 2005 Nov 1;11(21):7834-40
16278406
Proc Natl Acad Sci U S A. 2003 May 13;100(10):6039-44
12716967
Nat Biotechnol. 2004 Aug;22(8):969-76
15258594
J Pharm Biomed Anal. 2007 Mar 12;43(4):1290-6
17127025
Br J Cancer. 2006 Sep 4;95(5):601-6
16909136
Ann Oncol. 2004 Mar;15(3):517-25
14998859
Clin Lung Cancer. 2006 May;7(6):417-9
16800969
Cancer Res. 2000 Dec 15;60(24):6950-7
11156395